![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/427 | (2006.01) |
A61P 25/00 | (2006.01) | ||
A61P 25/16 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 27/00 | (2006.01) |
(11) | Number of the document | 2276485 |
(13) | Kind of document | T |
(96) | European patent application number | 09735906.1 |
Date of filing the European patent application | 2009-04-24 | |
(97) | Date of publication of the European application | 2011-01-26 |
(45) | Date of publication and mention of the grant of the patent | 2014-07-16 |
(46) | Date of publication of the claims translation | 2014-10-27 |
(86) | Number | PCT/US2009/041634 |
Date | 2009-04-24 |
(87) | Number | WO 2009/132253 |
Date | 2009-10-29 |
(30) | Number | Date | Country code |
47729 | 2008-04-24 | US |
(72) |
ALBRIGHT, Charles, F., US
BARTEN, Donna, Marie, US
LEE, Francis, Y., US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road P.O. Box 4000, Princeton, NJ 08543-4000,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Epotilono D panaudojimas su Tau susijusių ligų, įskaitant Alchaimerio ligą, gydymui |
USE OF EPOTHILONE D IN TREATING TAU-ASSOCIATED DISEASES INCLUDING ALZHEIMER`S DISEASE |
Payment date | Validity (years) | Amount | |
2016-03-21 | 8 | 185.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2017-04-24 |